DrugPatentWatch Database Preview
FIRMAGON Drug Profile
Which patents cover Firmagon, and what generic alternatives are available?
Firmagon is a drug marketed by Ferring and is included in one NDA. There are three patents protecting this drug.
This drug has one hundred and twenty-six patent family members in thirty-six countries.
The generic ingredient in FIRMAGON is degarelix acetate. One supplier is listed for this compound. Additional details are available on the degarelix acetate profile page.
Summary for FIRMAGON
| International Patents: | 126 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 26 |
| Clinical Trials: | 39 |
| Patent Applications: | 8 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FIRMAGON |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FIRMAGON |
| DailyMed Link: | FIRMAGON at DailyMed |
Generic Entry Opportunity Date for FIRMAGON
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for FIRMAGON
| 214766-78-6 |
| 766D786 |
| 934016-19-0 |
| Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2 |
| Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide |
| AKOS030526717 |
| AN-5181 |
| ASP-3550 |
| ASP3550 |
| BDBM50102450 |
| CHEBI:135961 |
| CHEMBL2028987 |
| CHEMBL415606 |
| CS-5350 |
| D08901 |
| D09400 |
| DB06699 |
| Degarelix |
| Degarelix (acetate) pound>>FE 200486 |
| Degarelix (INN/USAN) |
| Degarelix [USAN:INN:BAN] |
| Degarelix acetate |
| Degarelix acetate (JAN) |
| Degarelix monoacetate |
| EXT215F4ZU |
| FE 200486 |
| FE-200486 |
| FE-200486 (free base) |
| FE200486 |
| FE200486 (AS ACETATE SALT) |
| Firmagon (TN) |
| Gonax |
| GTPL5585 |
| HSDB 7817 |
| HY-16168A |
| QC-10170 |
| RL02641 |
| SCHEMBL1397034 |
| SX0XJI3A11 |
| Uglypeptide1 |
| UNII-EXT215F4ZU |
| UNII-SX0XJI3A11 |
| Z-3147 |
US Patents and Regulatory Information for FIRMAGON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for FIRMAGON
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1025104 | ➤ Sign Up |
| Norway | 994906 | ➤ Sign Up |
| Hungary | 0002704 | ➤ Sign Up |
| Brazil | 9808523 | ➤ Sign Up |
| Japan | 2011511786 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for FIRMAGON
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1003774 | 300395 | Netherlands | ➤ Sign Up | 300395, 20180413, EXPIRES: 20230412 |
| 1003774 | PA2009005,C1003774 | Lithuania | ➤ Sign Up | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
| 1003774 | 122009000033 | Germany | ➤ Sign Up | PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217 |
| 1003774 | 09C0028 | France | ➤ Sign Up | PRODUCT NAME: DEGARELIX, SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, EN PARTICULIER ACETATE; REGISTRATION NO/DATE IN FRANCE: EU/1/08/504/001 DU 20090217; REGISTRATION NO/DATE AT EEC: EU/1/08/504/001 DU 20090217 |
| 1003774 | C01003774/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
